APOE e4

Related by string. * ApoE . apoE . apo E : APOE e4 allele . APOE genotype . apolipoprotein E APOE . APOE allele . APOE epsilon 4 . APOE ε4 . gene APOE . APOE gene . ApoE gene . APOE / E4 . E4D : E4 Philosophy . e4 c5 2 . E4 +1 . e4 e5 2 . Apolipoprotein E4 . apolipoprotein E4 . e4 allele . e4 e5 . E4 More4 . E4 Skins . E4 variant . E2 E4 . Purifier e4 . E4 Udderbelly . GEM e4 . e4 * APOE e4 gene *

Related by context. All words. (Click for frequent words.) 79 APOE4 74 ApoE4 73 APOE ε4 73 ApoE4 gene 72 APOE gene 72 APOE e4 gene 71 UGT#A# * 71 APOE genotype 71 #q# deletion 71 apolipoprotein E 71 APOE4 gene 71 ABCB1 70 KIF6 gene 70 ApoE gene 70 ApoE4 allele 70 APOE 70 noncarriers 70 MYH9 gene 70 ε4 70 APOC3 70 TGFBR1 * 6A 70 rs# [002] 70 variant alleles 69 apolipoprotein E gene 69 APOE allele 69 apolipoprotein E4 69 TCF#L# gene 69 BRCA1 mutations 69 thyrotropin levels 69 BRCA mutation 69 rs# [004] 69 CYP#C# [001] 69 sporadic ALS 69 G allele 69 heterozygotes 68 GSTM1 68 MLH1 68 e4 allele 68 rs# [001] 68 MTHFR 68 K ras mutations 68 familial ALS 68 CDKN2A 68 gene APOE 68 germline mutations 68 BRCA2 gene mutation 68 elevated triglyceride levels 68 CYP#C# * 68 elevated homocysteine 67 genetic variants associated 67 HFE gene 67 MSH2 67 variant allele 67 gene variant 67 apolipoprotein E APOE 67 apoE4 67 susceptibility gene 67 #q#.# [001] 67 ApoE 67 Genetic variants 67 colorectal neoplasia 67 Wwox 67 chromosomal aberrations 67 familial pancreatic cancer 67 CAG repeats 67 PTEN gene 66 BRCA2 carriers 66 microdeletions 66 DQB1 * 66 CHEK2 66 HLA B# 66 troponin T 66 LRP5 66 advanced adenoma 66 GSTM1 gene 66 DRD2 66 C#Y 66 familial adenomatous polyposis 66 colorectal adenoma 66 APOL1 66 subclinical atherosclerosis 66 LPA gene 66 cardioembolic stroke 66 homozygotes 66 genes predisposing 66 mosaicism 66 narcolepsy cataplexy 66 NNRTI resistance 66 TCF#L# 66 HNPCC 66 missense mutations 66 KIF6 66 autonomic dysfunction 66 GG genotype 66 T1DM 66 genetic polymorphisms 66 GBA mutations 66 IgA deficiency 66 KRAS mutations 66 GSTT1 65 BMPR2 65 proband 65 BRCA2 mutation carriers 65 PTPN# 65 prostate carcinogenesis 65 dysbindin 65 MYH9 65 microsatellite instability 65 ZNF# 65 BARD1 65 subclinical hypothyroidism 65 penetrance 65 genetic variant 65 de novo mutations 65 gene polymorphism 65 NKX2 65 HbF 65 genetic polymorphism 65 postoperative delirium 65 HER2 overexpression 65 diabetes mellitus DM 65 microdeletion 65 LQTS 65 thyrotropin 65 mutated K ras 65 CC genotype 65 prostate cancer CaP 65 enteroviral infection 65 STAT4 65 TP# mutations 65 MetS 65 fasting glucose levels 65 familial hypercholesterolemia 65 subclinical hyperthyroidism 65 nonischemic 65 5 HTTLPR 65 MGUS 65 Asymptomatic 65 chromosome #p# [001] 65 MIF gene 65 Hashimoto thyroiditis 65 arterial calcification 65 CNTNAP2 65 serum BDNF 65 mutated BRCA1 64 apoE 64 homozygosity 64 CYP#C# [002] 64 C. pneumoniae 64 Fragile X gene 64 BRCA1 BRCA2 64 elevated CRP 64 SNP rs# [001] 64 subclinical 64 SNP rs# [002] 64 TMEM#B 64 genomewide 64 KRAS oncogene 64 EBV infection 64 rs# [003] 64 microbleeds 64 sCJD 64 gastric carcinogenesis 64 affective psychoses 64 GSTP1 64 BRCA2 gene 64 allele 64 ovarian hormones 64 CYP#D# 64 poor metabolizers 64 familial clustering 64 T2DM 64 somatic mutations 64 chromosome #q# [001] 64 MnSOD 64 SE alleles 64 cognitively normal 64 atypical hyperplasia 64 inherited mutations 64 GPC5 64 transferrin saturation 64 FGFR2 64 fetuin 64 Clusterin 64 elevated triglycerides 64 Multivariate analysis 64 multivariate Cox 64 biochemical abnormalities 64 #q# [001] 64 SGPT 64 SHANK3 64 missense mutation 64 folate deficiency 64 clusterin 64 heterozygous 64 cerebral infarction 64 PTEN mutations 64 MTHFR gene 64 PCa 64 BRCA2 mutations 64 HLA DRB1 * 64 shorter telomere length 64 Haptoglobin 64 chromosomal regions 64 BRCA gene mutation 64 DAT1 64 shorter telomeres 64 monogenic 64 nondemented 64 HDL2 64 MEF2A 64 CALHM1 64 KIF6 gene variant 64 LRAT 64 ADPKD 64 TT genotype 64 atherogenic dyslipidemia 64 TMPRSS2 ERG fusion 64 gene APOE4 63 recessive mutations 63 autoimmune thyroid 63 HER2 expression 63 LV dysfunction 63 CCR5 delta# 63 p# activation 63 advanced neoplasia 63 nondiabetic 63 G6PD deficiency 63 hepatitis B infection 63 predisposing factor 63 OPRM1 gene 63 homozygote 63 TOMM# 63 HIV HCV coinfected 63 silent myocardial ischemia 63 albumin excretion 63 hypermethylated 63 #p# [001] 63 clade B 63 HLA DQ2 63 amnestic MCI 63 colorectal adenomas 63 CP CPPS 63 vasogenic edema 63 parkinsonism 63 #p#.# [002] 63 APOE e4 allele 63 LIS1 63 SLC#A# [002] 63 obstructive coronary artery 63 HMGA2 63 etiologic 63 hydroxyvitamin D levels 63 dopamine transporter gene 63 Hp2 2 63 T2D 63 insulin resistance syndrome 63 retinol binding protein 63 glycated hemoglobin levels 63 CMV infection 63 herpesviruses 63 seropositivity 63 KCNE2 63 serum urate levels 63 aneuploidy 63 ERBB2 63 hormone receptor negative 63 ADH1B * 63 Apolipoprotein E 63 #q#.# [002] 63 Lp PLA 2 63 CDH1 63 nonalcoholic steatohepatitis NASH 63 hereditary hemochromatosis 63 BRCA2 mutation 63 elevated ALT 63 polymorphism 63 Leydig cell 63 hereditary predisposition 63 protein tyrosine phosphatase 63 promoter polymorphism 63 VKORC1 63 MC4R gene 63 presymptomatic 63 prolonged QT interval 63 S#A# [002] 63 polyp recurrence 63 white matter hyperintensities 63 CIN2 + 63 multivariable analysis 63 chromosome #p#.# 63 susceptibility loci 63 2 diabetes T2D 63 E selectin 63 chromosomal rearrangement 63 IGFBP 63 cardiac troponin 62 lupus anticoagulant 62 SOD2 gene 62 carotid plaque 62 G#S mutation 62 alpha synuclein gene 62 KIBRA 62 B7 H3 62 FGF2 62 monoclonal gammopathy 62 genetic loci 62 apoC III 62 adiponectin levels 62 depressive symptomatology 62 JAK2 mutation 62 E4 variant 62 CYP#D# gene 62 antiphospholipid antibodies 62 testicular germ cell 62 pCR 62 serologic 62 #p#.# [001] 62 HLA DRB1 62 mutant allele 62 comorbid anxiety 62 intact parathyroid hormone 62 ATG#L# 62 leptin receptor 62 CHD7 62 CagA 62 CFTR gene 62 PON1 62 carotid IMT 62 COMT gene 62 KLF4 62 MLL2 62 HOMA IR 62 myeloproliferative 62 COX2 62 cytogenetic abnormalities 62 oxysterols 62 chlamydial infection 62 progressive neurodegenerative disorder 62 cTnT 62 Cystatin C 62 neurologic complications 62 V Leiden 62 MMSE score 62 mtDNA mutations 62 autosomal dominant disorder 62 cell adhesion molecule 62 promoter methylation 62 Genetic variation 62 autosomal recessive disease 62 fetal chromosomal 62 MMSE scores 62 allele frequencies 62 aneuploidies 62 Chlamydia pneumoniae 62 Prehypertension 62 abdominal adiposity 62 antibody titer 62 HBeAg 62 human leukocyte antigen 62 microalbuminuria 62 AGTR1 62 CaM kinase II 62 serum homocysteine 62 susceptibility locus 62 CFH gene 62 heterozygosity 62 fasting insulin 62 gestational diabetes mellitus 62 neurodevelopmental outcome 62 PALB2 62 hypercoagulable 62 gene variants 62 carotid bruit 62 62 resistin 62 thiopurine 62 SORL1 62 gallstone disease 62 untreated celiac disease 62 DNA methylation patterns 62 dysglycemia 62 coinfection 62 neurofibrillary 62 COL#A# 62 chromosomal instability 62 CYP#C# gene 62 susceptibility genes 62 LDL receptor 62 G#S [002] 62 Myocardial infarction 62 autosomal recessive 62 HER2 amplification 62 ADAM# 62 hyperhomocysteinemia 62 coagulation abnormalities 62 NP CRNs 62 alleles 62 BRCA mutations 62 ENPP1 62 habitual snoring 62 Rh factor 61 BDNF gene 61 GABRA2 61 normal karyotype 61 gastric carcinoma 61 histological subtype 61 estrogen receptor alpha 61 familial adenomatous polyposis FAP 61 p#INK#a 61 hepatocellular carcinomas 61 Li Fraumeni 61 TYMS 61 familial aggregation 61 RRM1 61 AML MDS 61 HLA DRB1 SE 61 plasma lipid 61 single nucleotide polymorphism 61 p# mutations 61 Upregulation 61 NAFLD 61 amnestic mild cognitive impairment 61 impaired endothelial 61 systemic lupus erythematosus SLE 61 HBsAg 61 IGFBP 3 61 psychiatric comorbidity 61 BRAF mutations 61 euthymic patients 61 RASSF1A 61 latent celiac disease 61 CYP#D# genotype 61 squamous cell lung cancer 61 Heterozygous 61 pre eclamptic 61 PTP1B 61 klotho 61 elevated fasting glucose 61 Subgroup analyzes 61 lung adenocarcinoma 61 hypovitaminosis D 61 glutamic acid decarboxylase 61 inflammatory biomarkers 61 TMPRSS2 ERG 61 progranulin gene 61 endometrial hyperplasia 61 FLT3 61 LRRK2 gene 61 causal variants 61 adrenal function 61 tumorigenicity 61 autoantibodies 61 haematopoietic 61 5q 61 periprocedural MI 61 β amyloid 61 virulence genes 61 JAK2 enzyme 61 hippocampal atrophy 61 SCA5 61 EGFR gene 61 #q#.# deletion syndrome 61 CNVs 61 spontaneous mutations 61 cystatin C 61 Hurthle cell 61 Raf MEK ERK 61 vascular cognitive impairment 61 #q# deletion syndrome 61 GH deficiency 61 thyroglobulin 61 #p# [003] 61 serum selenium 61 polymorphisms 61 IPAH 61 airway hyperresponsiveness 61 tryptase 61 eosinophil count 61 myeloperoxidase 61 chromosomal alterations 61 AAT deficiency 61 Multivariate analyzes 61 FMR1 61 HeFH 61 UGT#B# 61 HOTAIR 61 pathogenic mutations 61 OGG1 61 dopamine receptor gene 61 gene variation 61 SMAD4 61 dizygotic twins 61 homozygous 61 antioxidant supplementation 61 basal cell nevus syndrome 61 HLA B 61 alanine aminotransferase ALT 61 inherited predisposition 61 motor neuron degeneration 61 amyloid deposition 61 CD# expression [002] 61 monozygotic twins 61 airway hyper responsiveness 61 poorer prognosis 61 genes BRCA1 61 neuroligins 61 Alu elements 61 PARP inhibition 61 neurological abnormalities 61 MECP2 gene 61 immunized mice 61 amyloid pathology 61 chronic hepatitis cirrhosis 61 advanced adenomas 61 pilocytic astrocytomas 61 allelic 61 breast cancer genes BRCA1 61 CVD mortality 61 LRRK2 mutations 61 obesity insulin resistance 61 psychiatric comorbidities 61 PB1 F2 61 cryptogenic 61 Subgroup analysis 61 metabolic abnormalities 61 BRCA1 mutation carriers 61 neuropathologic 61 plasma folate 61 extrapyramidal symptoms 61 FTO variant 61 angiotensin converting enzyme 61 ALK gene 61 NF1 61 intensive statin therapy 61 GPR# [002] 61 heterotaxy 61 serum ferritin 61 metabolic syndrome MetS 61 M. pneumoniae 61 NF1 gene 61 CCR3 61 androgen receptor AR 61 TEAEs 61 genes CYP#C# 61 thrombophilia 61 polycystic ovary syndrome PCOS 61 serum creatinine levels 61 CSF biomarkers 61 impaired fasting glucose 61 PICALM 61 plasma kallikrein 61 serum PTH 61 Pgp 61 chromosomal translocations 61 STAT3 signaling 61 coronary artery calcification 61 p# mutation 61 pDCs 61 fetal malformations 61 ABCB1 gene 61 #q# [002] 61 PITX2 61 Angiotensin converting enzyme 61 phosphorylated tau 61 diagnostic biomarker 61 maternal serum 61 androgen receptor gene 61 BCL#A 61 GISTs 61 ALDH2 61 gene amplification 61 SLC#A# [001] 61 atherosclerotic lesions 61 esophageal squamous cell carcinoma 61 atherothrombotic disease 61 chromosomal abnormalities 61 chorioamnionitis 61 IGF2 61 SNPs pronounced snips 61 FXTAS 61 BLLs 61 SHANK3 gene 61 rheumatoid factor 61 splice variants 61 HMG CoA reductase inhibitors 60 YKL 60 mitochondrial toxicity 60 phenotypic expression 60 multivariable adjusted 60 serum triglycerides 60 BRAF gene 60 neurocognitive impairment 60 PDGFR 60 NKX#.# 60 clinically detectable 60 HepG2 cells 60 FMR1 gene 60 HGPS 60 leptin deficiency 60 PDE#A 60 neuritic 60 metabolic disturbances 60 neurocognitive deficits 60 serum folate 60 allelic variants 60 affective psychosis 60 FGFR2 gene 60 SNCA 60 recurrent VTE 60 untreated hypothyroidism 60 causative mutations 60 circulating EPCs 60 C#Y mutation 60 cardiolipin 60 WNK1 60 persistent pulmonary hypertension 60 clinically insignificant 60 alanine aminotransferase 60 elevated bilirubin 60 bowel polyps 60 miRNA genes 60 tHcy 60 ASCUS 60 bronchopulmonary dysplasia 60 SCN1A 60 lipid lowering medications 60 vimentin 60 dominantly inherited 60 elevated LDL cholesterol 60 angiotensin receptor blockers ARBs 60 CETP gene 60 alexithymia 60 ORMDL3 60 Prox1 60 urothelial carcinoma 60 telomere lengths 60 HNSCC 60 abnormal glucose metabolism 60 RBP4 60 autosomal dominant 60 endothelial activation 60 KIAA# 60 serous ovarian cancer 60 imatinib resistance 60 gastric adenocarcinoma 60 heritable variation 60 HGPIN 60 pharmacokinetic interaction 60 virological response 60 Histologic 60 carotid atherosclerosis 60 human leukocyte antigen HLA 60 genetic locus 60 comorbid depression 60 TSC1 60 neuropathological 60 inducible nitric oxide synthase 60 retrospective cohort 60 Cytogenetic 60 colorectal tumor 60 variceal bleeding 60 chromosome #q#.# [001] 60 KRAS mutation 60 adenoma 60 D dimer 60 anal HPV 60 de ath 60 multivariate analyzes 60 1 diabetes T1D 60 brain lesions 60 nonvertebral fracture 60 liver metastasis 60 hyperparathyroidism 60 osteopontin 60 eotaxin 60 mitochondrial dysfunction 60 transgenic mouse models 60 SCN5A 60 spontaneous preterm delivery 60 humanin 60 haplotype 60 folate intake 60 chromosomal deletions 60 serum calcium 60 hyperinsulinemia 60 myo inositol 60 dietary folate 60 ERCC1 60 MC1R 60 paternally inherited 60 TOP2A 60 MeCP2 gene 60 urine cytology 60 adenomatous polyps 60 cytokine interleukin 60 colorectal carcinoma 60 serum phosphate 60 PlGF 60 Smad3 60 Colon polyps 60 beta carotene supplementation 60 bacteriuria 60 neurocognitive function 60 primary ovarian insufficiency 60 MYCN amplification 60 genetic variants 60 nodal metastasis 60 aminotransferase 60 haptoglobin 60 5 HTT gene 60 selenium supplementation 60 macroalbuminuria 60 Li Fraumeni syndrome 60 neuronal dysfunction 60 aminotransferase levels 60 TP# gene 60 cholesteryl ester transfer 60 60 gene polymorphisms 60 coronary artery calcium 60 IL#B 60 systemic inflammation 60 sequence homology 60 chemokine receptor 60 IL#R 60 BRAF V#E mutation 60 phenotypic variation 60 Cognitive impairment 60 inhibin B 60 tumor suppressor protein 60 univariate analysis 60 albuminuria 60 lipid parameters 60 TRAF1 C5 60 C. trachomatis 60 anovulatory infertility 60 causative gene 60 IgG antibody 60 endophenotypes 60 R#W [002] 60 Heritability 60 grade cervical intraepithelial 60 Heavy menstrual bleeding 60 Janus kinase 60 KCNH2 60 kidney allograft 60 Immunohistochemical analysis 60 del 5q 60 RIP1 60 apolipoprotein B 60 lymphoproliferative disorders 60 homocysteine concentrations 60 nonalcoholic steatohepatitis 60 liver histology 60 gene locus 60 C Reactive Protein 60 genomic deletions 60 Darapladib 60 adiponectin concentrations 60 Genetic predisposition 60 NQO1 60 VaD 60 BRCA2 genetic mutations 60 SMN2 gene 60 soluble CD# ligand 60 lymphocytic 60 TPMT 60 neuroD2 60 mucinous 60 probands 60 APOE epsilon 4 60 serum IGF 60 AUDs 60 immunohistochemical 60 macrovascular disease 60 underlying pathophysiology 60 mg BID dose 60 HPV# 60 MAPK pathway 60 NFkB 60 transgene expression 60 MIF protein 60 Vitamin D insufficiency 60 cagA 60 caveolin 60 parous women 60 dopamine D4 receptor 60 hsCRP 60 alpha synuclein protein 60 impaired glucose metabolism 60 urine NGAL 60 System IPSS 60 cardiac troponin T 60 autopsied brains 60 perilipin 60 hypermethylation 60 histologic subtype 60 nicotinic receptor 60 endoglin 60 methylation patterns 60 mild cognitive 60 CEACAM1 60 untreated sleep apnea 60 polygenic 60 TP# mutation 60 variant rs# 60 tumor histology 60 NOMID 60 PON1 gene 60 serum markers 60 aldehyde dehydrogenase 60 NRTI resistance 60 allostatic load 60 BRAF V#E 60 IFN γ 60 HER2 gene 60 EGFR mutation 60 XMRV infection 60 CIN3 60 BCR ABL mutations 60 SRBD 60 cTnI 60 arterial thickening 60 K#R [002] 60 synuclein 60 cAMP signaling 60 STK# gene 60 monozygotic twin 60 MSMB 60 WT1 60 IDH1 60 UGT#A# 60 Fas ligand 60 hydroxyvitamin D concentrations 60 Uterine cancer 60 GRNCM1 60 malignant neoplasm 60 clefting 60 stratifying patients 60 IDH1 mutation 60 monocyte chemoattractant protein 60 enterovirus infection 60 heparanase 60 elevated LDH 60 germline mutation 60 genetic variation 60 TACI mutations 60 Vascular dementia 60 TEL AML1 60 triiodothyronine 60 hyperglycaemia 60 disease NAFLD 59 atypia 59 Polycystic ovary syndrome PCOS 59 substrate specificity 59 Lantus insulin 59 hepatic lipase 59 gestational diabetes mellitus GDM 59 testosterone supplementation 59 Posiphen 59 diabetic kidney 59 resected pancreatic cancer 59 #beta HSD1 59 thrombocytopenic 59 Genotypes 59 MDM2 59 colon tumors 59 plasminogen activator inhibitor 59 baseline HbA1c 59 osteosarcomas 59 protein kinase C 59 striatal dopamine 59 Brugada syndrome 59 estrogen receptor ER 59 heritable genetic 59 nondiabetic patients 59 thyroid carcinoma 59 molecular abnormalities 59 repeat allele 59 comorbid disorders 59 orthologs 59 recurrent UTI 59 androgen deprivation 59 neovascular 59 prenatally diagnosed 59 Comorbidities 59 heterozygote 59 mRNA expression 59 NPY gene 59 QTc prolongation 59 epistasis 59 CCL#L# 59 HRCT 59 asymptomatic PAD 59 TNF blocker therapy 59 airway responsiveness 59 Squamous 59 SORL1 gene 59 impaired insulin secretion 59 melatonin receptor 59 serine protease 59 microvascular disease 59 neuropsychiatric symptoms 59 hyper IgE syndrome 59 gene mutation 59 isoprostane 59 medulloblastomas 59 cytopathic 59 prolactin levels 59 modifier genes 59 hepatoma 59 artery stenosis 59 neurexin 59 IKK beta 59 renal cell carcinomas 59 biochemical relapse 59 mesotheliomas 59 prothrombotic 59 spirometric 59 DICER1 gene 59 DRD2 gene 59 confidence interval #.#-#.# 59 bile acid metabolism 59 null mice 59 carcinoembryonic antigen 59 paricalcitol 59 abnormal lipid 59 activated microglia 59 somatic mutation 59 UCP2 59 deleterious mutation 59 TIMP 1 59 extramedullary 59 dysbindin gene 59 Lp PLA2 59 extracolonic findings 59 XLHED 59 protein encoded 59 onset diabetes mellitus 59 pathological hallmark 59 Leydig cells 59 Cowden syndrome 59 type2 diabetes 59 fetal aneuploidy 59 SLITRK1 59 ACE2 gene 59 autistic traits 59 NIHSS score 59 COMT genotype 59 bexarotene 59 FOXP3 59 serum retinol 59 obstructive coronary 59 nonalcoholic fatty liver 59 number variations CNVs 59 plasma leptin 59 MDR1 59 FTO gene 59 PTEN protein 59 atherosclerotic lesion 59 mitochondrial mutations 59 FTO allele 59 immunocompetent 59 ADAMTS# 59 thyroid peroxidase 59 serum leptin 59 BRCA2 59 fluvastatin 59 Kufs disease 59 unmeasured confounders 59 atherothrombotic 59 aortic atherosclerosis 59 Arch Intern Med 59 tyrosine phosphorylation 59 nondiabetics 59 microcephalin 59 neutrophil counts 59 ductal adenocarcinoma 59 myeloproliferative diseases 59 superinfection 59 pathophysiologic 59 serum IgE 59 TSP1 59 ACh 59 lactate dehydrogenase LDH 59 albumin excretion rate 59 huntingtin gene 59 FTIs 59 prognostic marker 59 Cholinesterase Inhibitors 59 FTLD 59 transthyretin 59 receptor blocker 59 serum folate concentrations 59 Sjögren syndrome 59 lymphocyte counts 59 intravenous bisphosphonates 59 neuroinflammation

Back to home page